Immuno-Biological Laboratories Co (TSE:4570) Operating Cash Flow per Share : 円0.00 (TTM As of Sep. 2024)

View and export this data going back to 2007. Start your Free Trial

What is Immuno-Biological Laboratories Co Operating Cash Flow per Share?

Immuno-Biological Laboratories Co's operating cash flow per share for the three months ended in Sep. 2024 was 円0.00. Immuno-Biological Laboratories Co's operating cash flow per share for the trailing twelve months (TTM) ended in Sep. 2024 was 円0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Immuno-Biological Laboratories Co's Operating Cash Flow per Share or its related term are showing as below:

During the past 13 years, Immuno-Biological Laboratories Co's highest 3-Year average Operating Cash Flow per Share Growth Rate was 52.90% per year. The lowest was -123.60% per year. And the median was -55.20% per year.

TSE:4570's 3-Year OCF Growth Rate is not ranked ^*
in the Biotechnology industry.
Industry Median: 9.3
* Ranked among companies with meaningful 3-Year OCF Growth Rate only.

Immuno-Biological Laboratories Co Operating Cash Flow per Share Historical Data

The historical data trend for Immuno-Biological Laboratories Co's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Immuno-Biological Laboratories Co Operating Cash Flow per Share Chart

Immuno-Biological Laboratories Co Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Operating Cash Flow per Share

Get a 7-Day Free Trial

-69.25

-20.85

-10.01

2.84

14.36

Immuno-Biological Laboratories Co Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Sep24
Operating Cash Flow per Share	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Immuno-Biological Laboratories Co's Operating Cash Flow per Share

For the Biotechnology subindustry, Immuno-Biological Laboratories Co's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Immuno-Biological Laboratories Co's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Immuno-Biological Laboratories Co's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Immuno-Biological Laboratories Co's Price-to-Operating-Cash-Flow falls into.

Save Embed

;

Save Embed

;

Immuno-Biological Laboratories Co Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Immuno-Biological Laboratories Co's Operating Cash Flow per Share for the fiscal year that ended in Mar. 2024 is calculated as

Operating Cash Flow per Share (A: Mar. 2024 )	=	Cash Flow from Operations (A: Mar. 2024 )	/	Shares Outstanding (Diluted Average) (A: Mar. 2024 )
	=	133.775	/	9.313
	=	14.36

Immuno-Biological Laboratories Co's Operating Cash Flow per Share for the quarter that ended in Mar. 2024 is calculated as

Operating Cash Flow per Share (Q: Sep. 2024 )	=	Cash Flow from Operations (Q: Sep. 2024 )	/	Shares Outstanding (Diluted Average) (Q: Sep. 2024 )
	=	0	/	9.313
	=	0.00

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0.00

Immuno-Biological Laboratories Co Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Immuno-Biological Laboratories Co's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Immuno-Biological Laboratories Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immuno-Biological Laboratories Co Ltd (TSE:4570) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

1091-1 Naka Aza-Higashida, Gunma, Fujioka, JPN, 375-0005

Website

http://www.ibl-japan.co.jp

Immuno-Biological Laboratories Co Ltd focuses on research and development. It researches, develops, manufacture and supplies various immunological research reagents, and customized services. It is engaged in research and development of materials used in diagnostic products and valuable seeds and technology for protein production using transgenic silkworm cocoons, which make it possible to create valuable proteins as well as antibodies. It works on clinical reagents for cancer research. Its research scientists are producing inflammatory cytokines, growth factors & antibodies for use against these cancers.

Immuno-Biological Laboratories Co Headlines

No Headlines